Canada’s national spending on higher education institutions’ R&D increased 7.3% to $10.9 billion in 2009. In real or inflation-adjusted terms, the amount was $9.0 billion, a 3.2% increase. Spending for health sciences R&D was $4.4 billion, an increase of 9.1%, or 5.0% in adjusted terms. Spending for other natural sciences and engineering R&D increased 5.5%, […]
Sri Lanka’s first science and technology policy, launched at the National Science and Technology Commission (NASTEC) conference in July, has finally been given the go-ahead. NASTEC and multiple Sri Lankan science and technology institutes are currently formulating an implementation strategy. The policy aims to increase GDP investment in science from 0.13% to 1.5% by 2016 […]
Saudi Arabia will invest $385 billion over the next five years in universities. Up to $240 million annually has been designated for grants in science and technology research projects. University capacity will be increased from an estimated 850,000 students in 2009 to 1.7 million students. Twenty-five technology colleges, 28 technical institutes and 50 industrial training […]
Colombia’s science funding and research investment will increase if Congress passes a reform of its 1991 Constitution currently being drafted by the Colciencias (Department of Science, Technology and Innovation). The amendment would invest 10% of the royalties from government and private usage of oil, coal, gold, platinum and new minerals in research, totaling at minimum […]
Europe’s recession is causing major drug companies to decrease their forecasts and spending. After EU policymakers accepted a rescue fund in May totaling almost $1 trillion, countries have reduced or plan to reduce their health spending. Germany instituted a price freeze on drugs until 2013, Spain presented a 7.5% rebate on most name-brand products and […]
In 2009, Israel’s expenditure on civilian R&D, at current prices, declined 1.6% to NIS 32.8 billion ($8.6 billion), to account for 4.3% of GDP. Businesses spending amounted to 79% of the national expenditure on R&D and fell 2.6%, at constant prices, after a 2.5% increase in 2008. This reflects a spending decrease of 8.5% at […]
The Indian government has announced that Ayruveda, Siddha and Unani drugs will be required to undergo testing similar to that required of modern medicines prior to approval. The Central Drugs Standard Control Organization recently issued guidelines addressing clinical trial practices for traditional medicines. Makers of traditional medicine argue that because the guidelines were adapted from […]
The Taoiseach, Brian Cowen TD, announced in July a €359 million ($462 million) investment plan for research and innovation, which aims to strengthen links between research institutions and industry. The government’s Programme for Research in Third-Level Institutions (PRTLI) invests in physical infrastructure and research projects at higher education institutions. The plan, Cycle 5 of the […]
The EU has announced €6.4 billion ($8.3 billion) in funding this year for the Seventh Framework Program (FP7), marking a 12% increase over last year’s funding. It is estimated that 16,000 grants will be awarded. Among the areas designated to receive funding are health, which will receive €600 million, including €206 million for clinical trials, […]
The Chinese government has been instrumental in attracting multinational drug firms to the country for R&D. In 2008, as part of the 11th Five-Year Plan, the government initiated the $960 million New Drug Creation and Development Program to assist Chinese pharmaceutical R&D. Universities and institutes’ research collaborations with multinational drug companies are among the recipients […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

